Skip to main content

Table 2 Characteristics of chronic HCV-infected MSM and associated factors, Prevagay 2015, France – weighted data

From: Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015

 

Prevalencea)

Univariate analysis

Multivariable analysis

n

%

[CI95%]

PR

[CI95%]

p

PRa

[CI95%]

p

All (N = 2645)

26

0.7

[0.3–1.5]

      

City

 Lille

6

0.4

[0.1–1.1]

ref.

     

 Lyon

3

0.5

[0.08–3.0]

1.1

[0.1–8.4]

0.9

   

 Montpellier

3

0.3

[0.05–1.3]

0.6

[0.1–3.8]

0.6

   

 Nice

6

1.0

[0.3–1.9]

2.3

[0.6–9.1]

0.3

   

 Paris

8

0.8

[0.3–1.5]

1.9

[0.4–7.8]

0.4

   

Place of birth

 France

21

0.5

[0.2–1.0]

ref.

  

ref.

  

 Outside France

5

1.8

[0.4–7.3]

3.6

[0.7–18.0]

0.1

10.5

[3.8–28.9]

0.001

Place of residence

 France:

         

  - Town < 20,000 inhab.

3

0.06

[0.01–0.2]

ref.

  

ref.

  

  - Town 20,000 ≤ ≤ 100,000 inhab.

8

1.5

[0.3–6.5]

27.2

[3.3–222]

0.002

16.1

[2.4–106.8]

0.004

- Town > 100,000 inhab.

14

0.8

[0.4–1.6]

13.7

[2.6–71.3]

0.002

4.7

[0.7–31.3]

0.1

Outside France

1

0.2

[0.03–1.3]

3.6

[0.3–40.6]

0.3

0.3

[0.02–6.1]

0.5

Attendance of (during the previous year):

- Outdoor meeting places

 yes

9

0.3

[0.1–0.7]

0.3

[0.1–1.1]

0.07

   

 no

17

0.9

[0.4–2.1]

ref.

     

- Use of gay websites or use of mobile-based GPS applications

 yes

23

1.0

[0.5–2.1]

21.5

[4.7–98.4]

< 0.001

5.2

[1.0–27.9]

< 0.05

 no

3

0.05

[0.01–0.2]

ref.

  

ref.

  

UAI with casual partners (during the previous year)

 yes

25

1.7

[0.8–3.4]

14.3

[5.0–337.6]

0.001

11.0

[1.3–95.0]

0.03

 no

1

0.04

[0.006–0.3]

ref.

  

ref.

  

More than 10 sexual partners (during the previous year)

 yes

22

1.4

[0.6–3.1]

10.0

[2.3–44.0]

0.002

3.6

[1.1–12.3]

0.04

 no

4

0.1

[0.04–0.5]

ref.

  

ref.

  

At least one STI (during the previous year)

 yes

15

1.7

[0.8–3.4]

3.2

[0.8–13.1]

0.1

   

 no

11

0.5

[0.2–1.6]

ref.

     

Consumption of (before or during sexual intercourse, during the previous year)

- Alcohol (more than 6 glasses per day)

 yes

16

0.4

[0.2–0.8]

0.3

[0.08–1.0]

0.05

0.3

[0.1–0.8]

0.02

 no

10

1.2

[0.4–3.2]

ref.

  

ref.

  

- Chemsex (during the previous year)

 yes

20

3.5

[1.8–6.7]

11.3

[1.9–68.2]

0.008

3.8

[1.1–12.6]

0.03

 no

6

0.3

[0.06–1.6]

ref.

  

ref.

  

Slamming (lifetime)

 yes, without sharing of injection equipment

10

9.4

[3.3–24.1]

23.2

[5.0–109]

< 0.001

6.0

[1.6–23.3]

0.009

 yes and sharing of injection equipment

3

16.6

[3.5–52.6]

41.2

[6.2–271]

< 0.001

3.8

[1.5–9.7]

0.006

 No

13

0.4

[0.1–1.3]

ref.

  

ref.

  

Practices with casual partners (during the previous year)

- BDSM

 yes

11

1.5

[0.6–3.7]

2.5

[0.7–9.0]

0.1

   

 no

15

0.6

[0.2–1.5]

ref.

     

- Fisting

 yes

16

2.9

[1.1–7.7]

10.8

[2.7–42.9]

0.001

5.3

[2.0–14.0]

0.001

 no

10

0.3

[0.1–0.7]

ref.

  

ref.

  

HIV statusb)

 HIV + diagnosed

20

3.2

[1.6–6.3]

9.6

[1.8–52.2]

0.009

4.5

[1.1–18.5]

0.04

 HIV + undiagnosed

1

0.2

[0.03–1.5]

0.6

[0.05–7.5]

0.7

0.3

[0.01–6.6]

0.5

 HIV -

5

0.3

[0.1–1.6]

ref

  

ref.

  

Screening for hepatitis C (previous year)

 yes

12

0.3

[0.1–0.7]

0.3

[1.0–1.0]

0.06

0.2

[0.5–0.6]

0.006

 no or did not know

14

1.0

[0.4–2.4]

ref

  

ref.

  
  1. a) n and %: crude number and weighted prevalence of chronic HCV-infected MSM in the reported category. For instance, 21 chronic HCV-infected MSM reported to be born in France; the prevalence of HCV-infected MSM among those born in France is estimated to 0.5% [0.2–1.0]
  2. b) undiagnosed HCV or HIV (MSM unaware of their HCV or HIV status): HCV or HIV status confirmed by virologic analysis after respondent reported “negative” or “not certain of being negative” or “I don’t know” to the question on “status” in the self-administered questionnaire. Diagnosed HCV or HIV (MSM aware of their HCV or HIV status): HCV or HIV status confirmed by virologic analysis after respondent reported to be HIV or HCV positive in the self-administered questionnaire